Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steinhoff

Showing results (301-310 of 364) with videos related to

Pageof 37
Sort By:
Epilepsia|February 16, 2011
Management and long-term outcome in patients presenting with ictal asystole or bradycardiaAdam Strzelczyk, Margarethe Cenusa, Sebastian Bauer, et al.
Epilepsia|May 13, 2015
Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationshipDorotheé Kasteleijn-Nolst Trenité, Christian Brandt, Thomas Mayer, et al.
Epilepsy & Behavior : E&B|February 2, 2016
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in GermanyR D Nass, C Kurth, A Kull, et al.
Brain : a Journal of Neurology|October 23, 2002
Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathologyHenriette J Tschampa, Jochen W Herms, Walter J Schulz-Schaeffer, et al.
Epilepsy Research|November 20, 2019
Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? - A case seriesBernhard J Steinhoff, Matthias Bacher, Marko Blickhan, et al.
Epilepsia|April 5, 2013
Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia?Susanne Fauser, Charles Essang, Dirk Matthias Altenmüller, et al.
Chemistry and Physics of Lipids|February 4, 2019
Detergent-free solubilization of human Kv channels expressed in mammalian cellsM G Karlova, N Voskoboynikova, G S Gluhov, et al.
Epilepsia Open|November 15, 2025
Efficacy and safety of perampanel as first adjunctive therapy in patients with focal-onset seizures or generalized tonic-clonic seizures in four post-marketing studies across regionsStefano Meletti, Vineet Punia, Amitabh Dash, et al.
Brain : a Journal of Neurology|May 3, 2007
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillanceU Heinemann, A Krasnianski, B Meissner, et al.
Journal of Neurology|August 24, 2021
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practiceVicente Villanueva, Wendyl D'Souza, Hiroko Goji, et al.
Pageof 37

Showing results (301-310 of 364) with videos related to

Sort By:
Pageof 37
Epilepsia|February 16, 2011
Management and long-term outcome in patients presenting with ictal asystole or bradycardiaAdam Strzelczyk, Margarethe Cenusa, Sebastian Bauer, et al.
Epilepsia|May 13, 2015
Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationshipDorotheé Kasteleijn-Nolst Trenité, Christian Brandt, Thomas Mayer, et al.
Epilepsy & Behavior : E&B|February 2, 2016
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in GermanyR D Nass, C Kurth, A Kull, et al.
Brain : a Journal of Neurology|October 23, 2002
Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathologyHenriette J Tschampa, Jochen W Herms, Walter J Schulz-Schaeffer, et al.
Epilepsy Research|November 20, 2019
Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? - A case seriesBernhard J Steinhoff, Matthias Bacher, Marko Blickhan, et al.
Epilepsia|April 5, 2013
Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia?Susanne Fauser, Charles Essang, Dirk Matthias Altenmüller, et al.
Chemistry and Physics of Lipids|February 4, 2019
Detergent-free solubilization of human Kv channels expressed in mammalian cellsM G Karlova, N Voskoboynikova, G S Gluhov, et al.
Epilepsia Open|November 15, 2025
Efficacy and safety of perampanel as first adjunctive therapy in patients with focal-onset seizures or generalized tonic-clonic seizures in four post-marketing studies across regionsStefano Meletti, Vineet Punia, Amitabh Dash, et al.
Brain : a Journal of Neurology|May 3, 2007
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillanceU Heinemann, A Krasnianski, B Meissner, et al.
Journal of Neurology|August 24, 2021
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practiceVicente Villanueva, Wendyl D'Souza, Hiroko Goji, et al.
Pageof 37